The polyamines (spermine, putrescine, and spermidine) can have neurotoxic or neuroprotective properties in models of neurodegeneration. However, assessment in a model of hypoxiaischemia (HI) has not been defined. Furthermore, the putative mechanisms of neuroprotection have not been elucidated. Therefore, the present study examined the effects of the polyamines in a rat pup model of HI and determined effects on key enzymes involved in inflammation, namely, nitric oxide synthase (NOS) and arginase. In addition, effects on mitochondrial function were investigated. The polyamines or saline were administered i.p. at 10mg/kg/day for 6 days post-HI. Histological assessment 7 days post-HI revealed that only spermine significantly (P<0.01) reduced infarct size from 46.14 ± 10.4mm 3 (HI + saline) to 4.9 ± 2.7 mm 3 . NOS activity was significantly increased following spermine treatment in the left (ligated) hemisphere compared with nonintervention controls (P<0.01) and HI + saline (P<0.05). In contrast, spermine decreased arginase activity compared with HI + saline but was still significantly elevated in comparison to nonintervention controls (P<0.01). Assessment of mitochondrial function in the HI + saline group, revealed significant and extensive damage to complex-I (P<0.01) and IV (P<0.001) and loss of citrate synthase activity (P<0.05). No effect on complex II-III was observed. Spermine treatment significantly prevented all these effects. This study has therefore confirmed the neuroprotective effects of spermine in vivo. However, for the first time, we have shown that this effect may, in part, be due to increased NOS activity and preservation of mitochondrial function.
The naturally occurring polyamines, putrescine, spermine, and spermidine, are important for cell growth, proliferation, regeneration, and differentiation (3) . In addition, their involvement in cell homeostasis extends to regulatory mechanisms of programmed cell death (4), modulation of nitric oxide synthase activity (NOS; 5), regulation of mitochondrial Ca 2+ transport (6, 7), inhibition of mitochondrial membrane permeability (8) , and free radical scavenging (9, 10) .
The polyamines are low molecular-weight aliphatic amines, present in moderately high concentrations in the brain. Their production is regulated by ornithine decarboxylase (ODC), which converts ornithine to putrescine (11) . Previous studies have shown that the polyamines play an important role in the ischemic cascade (12, 13) . Changes in the pathophysiological state of the body as a result of an ischemic insult result in significant changes to ODC activity and putrescine levels (14, 15) . Most importantly, an increase in ODC activity and putrescine levels can occur with little or no change to spermidine or spermine levels (14, 15) . It has also been demonstrated that elevated polyamine levels consequent to an ischemic event are implicated in neuronal damage (16) (17) (18) (19) . In addition, elevated levels of putrescine have been shown to result in blood-brain barrier dysfunction as well as vasogenic edema in ischemic events (15) (16) (17) .
The involvement of polyamines in the pathophysiology of ischemic damage has not, as yet, been fully elucidated. Both global and focal models of brain ischemia have shown evidence of increased polyamine metabolism, characterized by an increase in ODC activity and putrescine levels. In contrast, the concentration of endogenous spermine in the brain has proven variable under different pathophysiological conditions. In a model of global ischemia, spermine levels are either slightly reduced (20) , or somewhat elevated (21) , whereas, in a model of focal ischemia, spermine levels are either considerably reduced (22) , or unaltered (14) .
To date, no study has ascertained the effects of exogenous administration of the polyamines in a model of HI-induced brain damage. Furthermore, the mechanisms of a putative polyamineinduced neuroprotection remain undetermined. Therefore, in this study, we have used a modified "Levine" rat-pup model (unilateral carotid artery ligation, coupled with global hypoxia), to evaluate the effects of the polyamines on HI-induced brain damage. We have also investigated the biochemical and molecular energetic implications associated with these effects.
METHODS

Surgery and treatment
All procedures were carried out in accordance with the guidelines on care and use of laboratory animals by the University of Otago Animal Ethics Committee. Male Wister rat pups, of age postnatal-day (PND) 21 were randomly sorted into 5 groups: untreated, no intervention controls, HI + saline controls, HI + spermidine, HI + spermine and HI + putrescine. A total of n = 6 animals per group were used for histological analysis of infarct size and n = 8 animals per group for biochemical and molecular analysis.
On PND 26, a small longitudinal incision was made along the neckline under halothane anesthesia, and the left common carotid artery was exposed and permanently double-ligated using 5-0 silk surgical sutures (Southern Medical Products, Dunedin, NZ). The incision was then closed with 4-0 sutures and animals were left to recover for a period of 2 hours. After recovery, animals were placed in a chamber maintained at 34°C, constantly perfused with a humidified hypoxic atmosphere of 8% O 2 /92% N 2 for a period of 60 min. Animals were then returned to normal housing conditions until 7 days post-HI, at which time assessment of neuroprotection was carried out. Drug (putrescine, spermine, and spermidine) administration was carried out with a single i.p. injection of 10 mg/kg, 1hour post-HI, and then subsequently once daily for the next 6 days. This dose is based on the finding that 10 mg/kg of putrescine, spermine, or spermidine resulted in a significant neuronal protection of CA1 and striatal neurons in a gerbil model of forebrain ischemia (23) .
Histological assessment
Histological assessment at 7 days post-HI (PND 33) was carried out using hematoxylin and eosin (H and E) staining. Animals were deeply anaesthetized with 3% halothane. Briefly, the chest cavity was opened and the heart perfused with heparinized saline followed by 10% phosphatebuffered formalin. The brains were then removed and immediately stored in the same fixative until embedded in paraffin wax. 10 µm serial sections were cut at 1 mm intervals throughout the brain and stained with H and E. Computer image analyses (Zeiss Axiovision, Thornwood, NY, USA) of the histological sections were used to quantify the extent of neuronal infarct. The area of infarct (mm 2 ) within the ipsilateral (left) hemisphere was normalized against the total noninfarcted area in the right hemisphere. The total volume (mm 3 ) of infarction was then determined by calculating the area for each point throughout the brain (every 1mm) and an area under the curve formula used (GraphPad Prism, version 3.0a, San Diego, CA, USA).
Tissue preparation for biochemical and mitochondrial analysis
Animals were rapidly killed by decapitation, brains were removed, and the left and right hemispheres were dissected. Tissues were immediately frozen on dry ice and stored at -80°C until use. The samples were then homogenized on ice (4°C) in a mixture of protease inhibitors (10 µg/ml leupeptin, 10 µg/ml pepstatin A and 100 µg/ml phenylmethylsulphonyl fluoride) in 50 mM Tris-HCl, pH 7.5. Samples were centrifuged for 15 min at 2,000 g (4°C) and supernatants aliquoted for each assay.
For mitochondrial enzyme assays, samples of tissue homogenates were freeze-thawed three times to ensure complete mitochondrial lysis. Samples were then diluted to 1 mg/ml in 10 mM Tris-HCl, pH 7.4 containing 320 mM sucrose and 1 mM K + EDTA and stored at -80°C.
Protein concentrations for all samples were assayed using the Bradford assay (24) against bovine serum albumin (BSA) standards.
Nitric oxide synthase activity
Homogenates were incubated for 30 min at 37°C in 50 mM Tris (pH 7.4), containing NADPH (1mM), calmodulin (30nM), tetrahydrobiopterin (5µM), CaCl 2 (2mM), L-Valine (50mM) and the substrate (a mixture of unlabeled and 10µM [ 3 H] L-arginine). To assess the contribution of iNOS (calcium-independent) from total NOS (calcium-dependent), the reaction was then repeated in the absence of CaCl 2 and presence of 1 mM EGTA. Following incubation, the reaction was stopped, by the addition of ice-cold HEPES buffer (20mM, pH 5. 
Mitochondrial complex I assay
The reaction mixture contained 25 mM phosphate buffer pH 7.2, 0.2 mM NADH, 10 mM MgCl 2 , 1 mM KCN, 2.5 mg BSA and 12 µg of tissue homogenate protein in a final volume of 260 µl. The reaction was initiated by the addition of ubiquinone (CoQ 1 ; to give a final concentration of 50 µM) and read at 340 nm for 5 min. The inhibited rate was then measured in the presence of 0.5 mM rotenone for a further 5 min. Results are expressed as nmol/min/mg protein.
Mitochondrial complex II-III assay
To a reaction mixture containing 100 mM phosphate buffer pH 7.4, 0.3 mM K + EDTA, 1 mM KCN and 100 µM cytochrome c, 12 µg of tissue homogenate protein was added to give a final volume of 260 µl. The reaction was initiated by the addition of 20 µl of 1M succinate, and read at 550 nm at 30°C for 5 min. After this time, 10 µl of 2 mg/ml antimycin A was added, and the inhibited rate measured for a further 5 min. Results are expressed as nmol/min/mg protein.
Mitochondrial complex IV assay
The reaction mixture contained 10 mM phosphate buffer pH 7.0, 50 µM reduced cytochrome c and 1 mM K 3 FeCN 6 in a final volume of 260 µl. The reaction was initiated by the addition of 12 µg tissue homogenate protein. The first-order rate constant (k) was calculated as the difference between the natural logarithms of the absorbance at t = 0 and at three time points-1, 2, and 3-min following addition of mitochondrial protein. The mean of these values (k) was taken, and the activity was expressed as k/min/mg protein.
Citrate synthase assay
The reaction mixture contained 100 mM Tris-HCl pH 8.0, 0.1 mM acetyl-CoA, 0.2 mM 5,5′ dithio-bis 2-nitrobenzoic acid, 0.1% (v/v) Triton X-100, and 12 µg of tissue homogenate protein in a final volume of 260 µl. The reaction was initiated by the addition of 10 µl of 20 mM oxaloacetate and read at 412 nm at 30°C. Results are expressed as nmol/min/mg protein.
Lactate dehydrogenase assay
Lactate dehydrogenase (LDH) activity in tissue samples was assessed using a commercially available kit (Sigma, Castle Hill, New South Wales, AU). The reaction mixture contained 4 parts of reagent B (16.2 mM pyruvate in Tris-base pH 7.5) to 10 parts of reagent A (0.194 mM NADH in 54 mM phosphate buffer pH 7.5) in a final volume of 290 µl. The reaction was initiated by the addition of 40 µg of tissue homogenate protein. LDH activity was calculated as the difference between the natural logarithms of the absorbance at 340 nm at 25°C for three time points; 1-, 2-, and 3-min following addition of tissue homogenate protein and is based on the conversion of NADH to NAD + . Results are expressed as U/L.
Statistics
Results are expressed as the mean ± SEM for n = 6-8 separate observations. Statistical analysis was performed using two-way ANOVA. The Mann-Whitney U-test was used to determine significance at individual points throughout the brain for each group. Student Newman-Keuls test was used for enzymatic post-hoc comparisons between control and treatment groups. A P value of <0.05 was considered significant.
RESULTS
Histological effects of polyamines on HI-induced brain damage
During the time course of HI and drug administration, body weight, temperature and blood glucose levels were monitored and shown not to vary between treatment groups (data not shown).
H and E staining 7 days post-HI revealed extensive neuronal damage ipsilateral to the carotid ligation, with no apparent anatomical damage contralaterally in the HI + saline-treated animals ( Fig. 1 ). The extent of neuronal damage following HI + saline extends through all cortical layers (Fig. 1A) , likewise all areas of the hippocampus (Fig. 1C) . Treatment with spermine preserved anatomical regions in both the cortex and hippocampus ( Fig. 1B and D, respectively), against HIinduced damage. Of the polyamines, only spermine significantly (P<0.01) decreased the infarct volume (4.9±2.7mm
3 ) compared with HI + saline (46.14±10.4mm 3 ). Quantification of the effects of the polyamines throughout the whole brain is shown in Fig. 2 .
Effect of spermine on NOS activity
Spermine was the only polyamine that resulted in a significant neuroprotection (Fig. 2) . Therefore, all subsequent biochemical and molecular analysis were only performed on sperminetreated animal samples. NOS activity 7 days post-HI revealed a significant increase in iNOS activity (absence of calcium) in the left (ligated) hemisphere from HI + saline-treated animals (P<0.05; Fig. 3B ) compared with nonintervention controls. No change was seen in total NOS activity (addition of calcium) in the left hemisphere from HI + saline-treated animals (Fig. 3B) . Treatment with spermine resulted in a significant increase in total NOS activity in comparison to nonintervention controls (P<0.01) and HI + saline (P<0.05), with no change in iNOS activity (Fig. 3B) , compared with HI + saline controls. Assessment of iNOS and total NOS activity in the right (nonligated) hemisphere, failed to reveal any significant differences between treatment groups (Fig. 3A) .
Effect of spermine on arginase activity
Assessment of arginase activity in the left hemisphere of HI + saline-treated animals showed a significant increase in activity from 33.6±1.6 (nonintervention controls) to 58.9 ± 8.1 µg urea/mg protein (P<0.01; Fig. 4B ). Treatment with spermine decreased arginase activity (45.7±2.0µg urea/mg protein) in comparison to HI + saline controls. However, the level of activity was still significantly up-regulated compared with untreated controls (P<0.01; Fig. 4B ). Assessment of arginase activity in the right hemisphere, failed to reveal any significance between any groups (Fig. 4A) .
Effect of spermine on Complex I activity
Complex I activity was significantly impaired in the left hemisphere following HI + saline (P<0.01; Fig. 5A ), compared with nonintervention controls. Treatment with spermine reversed the HI-induced impairment of complex I to near normal nonintervention control levels of activity (P<0.01). Assessment of complex I activity in the right hemisphere failed to show any significant differences between any groups.
Effect of spermine on Complex II-III activity
Mitochondrial complex II-III activity for both hemispheres elicited no change in activity between any groups (Fig. 5B) .
Effect of spermine on Complex IV activity
Hypoxia-ischemia resulted in a decrease in complex IV kinetics from 6.44 to 2.49 k/min/mg protein in the left hemisphere (P<0.001; Fig. 5C ), compared with nonintervention controls. Spermine treatment provided significant protection to mitochondrial complex IV kinetics (P<0.001) compared with HI + saline, but was still down-regulated compared with nonintervention controls. No change in mitochondrial complex IV kinetics was seen in the right hemisphere between any groups.
Effect of spermine on citrate synthase activity
The mitochondrial membrane matrix marker, citrate synthase was significantly impaired in the left hemisphere following HI + saline (P<0.05; Fig. 5D ), compared with nonintervention controls. Treatment with spermine-preserved citrate synthase activity to nonintervention control levels of activity (P<0.05). Assessment of citrate synthase activity in the right hemisphere failed to show any significant differences between any groups.
Effect of spermine on LDH activity
Assessment of LDH activity showed a significant decrease in the left hemisphere following HI + saline (P<0.001; Fig. 6 ), compared with nonintervention controls. Treatment with spermine reversed the HI-induced decrease in LDH activity back to nonintervention control levels (P<0.001). In contrast, LDH activity in the right hemisphere was increased following HI + saline, but this was not significant compared with the right hemisphere of the nonintervention controls. No change in LDH activity compared with nonintervention controls was seen in the right hemisphere following HI + spermine treatment.
DISCUSSION
The present study illustrates that HI induces pronounced lesions across cortical and subcortical regions ipsilateral to a carotid occlusion. In addition, modulation of critical biochemical enzymes, namely NOS and arginase and substantial impairment in mitochondrial energetics occurs following HI. Acute (6 days) administration of the polyamines showed that only spermine provided anatomical neuroprotection and virtually full preservation of mitochondrial energetics.
Our findings that HI produces substantial CNS damage ipsilateral to the occlusion, is consistent with those of other groups in this field. H and E staining, 7 days post-HI, revealed widespread regions of damage. Spermine provided significant neuroprotection. This is in keeping with previous work that has shown spermine to be neuroprotective in a model of forebrain ischemia (23) . In this study, i.p. administration of spermine decreased the number of both hippocampal and striatal cell loss. A number of studies have also shown that the polyamines are neuroprotective, both in vivo (25, 26) , and in vitro (27, 28) , though spermine appears to provide the greatest amount of protection. However, in this study neither putrescine nor spermidine showed any neuroprotective effects. We have therefore confirmed the neuroprotective effects of spermine but have extended these observations by determining the biochemical and molecular events associated with these observations. Nitric oxide (NO) is a key component in the brain's response to HI-induced damage. NOS, of which three isoforms exist (iNOS, nNOS, and ecNOS), converts L-arginine to NO and Lcitrulline. The present study showed an increase in iNOS activity in response to HI. However, this increase in iNOS activity only accounted for a minority of the total NOS activity, as shown in Fig. 3 . Previous work has demonstrated that iNOS-derived NO is deleterious (29) and that iNOS knockout mice are more resistant to ischemic episodes (30) . Furthermore, mice lacking the nNOS gene are more resistant to ischemic damage (31) . In contrast, NO from ecNOS is neuroprotective, as ecNOS knockout mice have increased infarctions in comparison to their wild-type controls (32) . Therefore, NO can be both neurotoxic if it is from iNOS or nNOS, but neuroprotective if derived from ecNOS. We have shown that treatment with spermine resulted in a further increase in total NOS activity in comparison to HI. This increase in total NOS activity is most likely to be attributed to an increase in either ecNOS or nNOS activity. Our findings therefore further support the evidence that an elevation of total NOS activity, in the absence of an increase in iNOS activity, is neuroprotective.
To date, little, if anything, is known about the pathoneurological role of the other L-argininemetabolizing enzyme arginase. Arginase metabolizes L-arginine to urea and L-ornithine, which is the first step in the production of the polyamines. Because both NOS and arginase use L-arginine as a common substrate, modulating the activity of arginase may subsequently regulate the activity of NOS (33) . The present study resulted in an elevated level of arginase activity following HI, which was reduced with spermine treatment. Thus, spermine increased NOS and decreased arginase activity with resultant neuroprotection. Therefore, we hypothesize that exogenous administration of spermine indirectly suppresses arginase activity, with a resultant utilization of L-arginine by the NOS pathway. This leads to an increase in NO levels and thus results in neuroprotection.
Investigations over the past decade have substantiated mitochondria as being important subcellular targets for ischemic damage. It has been observed that brain mitochondrial respiratory chain complexes undergo significant changes in activity following an ischemic event, both in vivo and in vitro (34-38). As evidenced in the present study, HI-induced substantial damage to mitochondrial respiratory energetics. This decrease in mitochondrial energetics is consistent with other models of ischemic brain damage (39). A key finding in the present study was that spermine provided virtually complete preservation of mitochondrial respiratory chain complex activity.
Elevation of reactive oxygen species (ROS) and the resulting oxidative stress plays a pivotal role in neuronal damage. Accumulation of ROS and cytosolic Ca 2+ may impair metabolic enzymes required for substrate production or promote disruption of mitochondrial membranes. ROS production has been shown to inhibit pyruvate dehydrogenase through oxidation, a process that is potentiated by elevated Ca 2+ (40). These changes could explain the deficits seen at the level of complex I observed in the present study following HI. This decrease in activity has previously been seen in brain mitochondria following an ischemic episode, in which a decrease in state 3 NAD-linked respiration rates were observed (41). Inhibition of complex I activity, unlike the other complexes, leads to a rapid decrease in oxygen consumption initiating oxidative stress (42). This oxidative stress then triggers a sudden rise in Ca
2+
, as a consequence of inhibition of oxidative phosphorylation, preventing the energy-dependent pumping of Na + and Ca 2+ out of the cell, while continuously leaking Ca 2+ into the cell at a normal rate (43). Spermine can restore phosphorylation in mitochondria isolated from liver that have been subjected to heat stress (44). The results of this study, therefore, confirm and extend pervious observations. In addition to the effects of HI on complex I activity, other parts of the mitochondrial respiratory chain have been shown to be sensitive to stress-induced ROS. The formation of large quantities of oxygen free radicals has been proposed to initiate both lipid and protein peroxidation (45, 46). Complex IV is particularly susceptible to damage resulting from lipid peroxidation products (47) . In the present study, HI induced a significant decrease in complex IV activity, which was reversed by spermine treatment. This finding is in support of previous studies that have shown that the polyamines can inhibit lipid peroxidation (48) , suggesting that the damage seen to complex IV in our study is, in part, due to lipid peroxidation.
Citrate synthase activity was also significantly decreased following HI, indicating that mitochondrial structures were not intact, and that they were leaking important mitochondrial matrix components. Spermine provided full preservation of citrate synthase activity, protecting against the HI-induced mitochondrial membrane permeability. It has been demonstrated that spermine protects against mitochondrial membrane permeability transition, as measured by Ca 2+ release, mitochondrial swelling and pyridine nucleotide (8) .
Nitric oxide produced as a consequence of ischemic damage may react with other free radicals such as superoxide to form peroxynitrite (ONOO -), which is an extremely potent oxidizing agent (49, 50) . Peroxynitrite has been shown to directly inhibit complexes II-III and IV activities in cultured neurons (51) without affecting complex I activity. Here, we have shown that post HI, NOS activity is increased with concomitant damage to mitochondrial function. Thus, the formation of NO and or peroxynitrite could account for the damage to mitochondrial complex activity. However, spermine, which protected mitochondrial respiratory chain activity, further increased NOS activity. Furthermore, it has been shown in vitro, using cytosolic preparations of normal rat cerebellum, that large concentrations of spermine inhibit NOS activity (5). These results would initially seem contradictory. However, it now appears that the action of these endogenous compounds may be intrinsically interlinked and dependent on the relative concentration of each agent. In addition, the region of the brain studied and the state of activation may complicate interpretation of results.
The controversial range of actions reported is further confounded by the level of oxidative stress and other determining factors involved in the pathophysiological state of the tissue. Although pathophysiologically high levels of NO have been indicated to be detrimental to mitochondrial cytochrome redox state, targeting, in particular, the cytochrome oxidase super complex (complex IV) (52), low physiologically relevant NO levels have been shown to abrogate cardiac LDH release in association with a mitochondrial K ATP channel-dependent pathway of protection against ischemic reperfusion injury. Up-regulation of tissue LDH activity has been indicated to be dependent on an increased transcription of a hypoxia-inducing factor (53), stabilized intriguingly, by high levels of NO in a hypoxic (3% O 2 ) model (54) . Our model did show that decreased complex IV activity did in fact coincide with elevated iNOS activity within the infarcted left hemisphere. Both mitochondrial integrity, as assessed by the matrix marker, citrate synthase (55) , and LDH levels, were also severely compromised in this region. Spermine has also been shown to have a double-edged effect in that it can both inhibit (8, 56) and stimulate (57-59) cellular apoptosis through mitochondrial-linked pathways. This is through a modulatory effect of the N-methyl-D-aspartate (NMDA) receptor (60) . However, this is a concentrationdependent effect, whereby low doses (<50 nmol) attenuate NMDA-induced damage, whereas larger doses potentiate excitotoxicity (61) . Much of the evidence relating to spermine-mediated induction of mitochondrial cytochrome c release and caspase (3 and 9) activation is based on in vitro studies in cancer cell lines. Paradoxically, studies on neuronal cells, thymocytes, and in vivo cerebral tissue indicate a protective role for spermine, possibly mediated through a mitochondrial-related anti-apoptotic action. Ha and co-workers (9) also provided evidence to suggest that part of this protection may relate to a direct antioxidant capability of spermine. Spermine's neuroprotective role may also be contingent on an increased mitochondrial Ca 2+ buffering capacity. In our present study, spermine failed to provoke evidence of cellular or mitochondrial damage in either ipsilateral or contralateral regions. However, the results of this study clearly demonstrated that a daily regime of 10 mg/kg spermine, significantly restored left hemisphere indices of integrity and mitochondrial energetics damaged by HI. These effects coincided with a reduction in iNOS activity but not total NOS.
Lactate dehydrogenase is the enzyme catalyzed in the final step of the anaerobic metabolism, glycolysis, and is a key cytosolic marker. The present study resulted in a marked decrease in LDH activity following HI. In addition to the results of citrate synthase activity, this reinforces the hypothesis that the induction of HI results in a significant leak in the cytosolic membrane, which is preserved by treatment with spermine.
CONCLUSIONS
The present study demonstrates that following an HI insult, the lesioned (left) hemisphere undergoes extensive changes in both biochemical and mitochondrial energetics, which could account for a large proportion of the neuronal cell damage. Exogenous treatment with the naturally occurring polyamine spermine resulted in significant decrease in infarction size. This may be due to an up-regulation of NOS activity (more specifically ecNOS) and or a decrease in arginase activity. In addition, we have shown that HI results in severe impairment of mitochondrial function. Furthermore, spermine provided full preservation of mitochondrial respiratory chain energetics. This confirms and extends, our and other, previous studies, which have shown that NO is neuroprotective. More importantly, we speculate, for the first time, that modulation of the enzyme arginase may be a future, novel target for drug intervention in neurodegenerative pathologies. hemisphere, compared with nonintervention controls. Spermine treatment negated this increase in iNOS activity. However, this was not significantly different to either HI + saline nor nonintervention controls. Also, spermine treatment resulted in a significant increase in total NOS activity (P<0.05) in the left hemisphere, compared with HI + saline: + P < 0.05, ++ P < 0.01 vs. nonintervention control; *P < 0.05 vs. HI + saline. on mitochondrial respiratory chain complexes and the membrane permeability marker citrate synthase. Complexes I (A), II-III (B), IV (C) and citrate synthase (D) activities were assessed in tissue homogenates from both left and right hemispheres (data not shown). In the left hemisphere, HI alone resulted in a decrease in complex I, IV, and citrate synthase activities (P<0.01, P<0.001, and P<0.05, respectively), compared with nonintervention controls. In the left hemisphere, HI + spermine provided significant preservation of mitochondrial energetics at complex I, IV, and citrate synthase (P<0.01, P<0.001, and P<0.05, respectively), compared with HI + saline. No change in any complex or citrate synthase activity in the right hemisphere were observed (data not shown): + P < 0.05, ++ P < 0.01, +++ P < 0.001 vs. nonintervention control; * P < 0.05, ** P < 0.01, *** P < 0.001 vs. HI + saline. left (B) hemispheres. LDH activity was significantly impaired following HI + saline in the left hemisphere (P<0.001), compared with nonintervention controls. In the HI + saline group, LDH activity was elevated in the right hemisphere, though LDH activity was not significantly different to nonintervention controls (P=0.071). Spermine treatment resulted in a significant preservation of LDH activity (P<0.001), compared with HI + saline. Assessment following HI + spermine in the right hemisphere showed no change in activity compared with nonintervention controls and HI + saline. +++ P < 0.001 vs. nonintervention control; *** P < 0.001 vs. HI + saline.
